PH
PHILOCHEM AG
Grant-FundedCORDISSmall-Molecule Drug Conjugates for Targeted Delivery in Tumor Therapy
Biotech
PHILOCHEM AG is a private SME recorded in CORDIS in Switzerland, with participation in 5 EU research and innovation projects. Its recorded projects include “Small-Molecule Drug Conjugates for Targeted Delivery in Tumor Therapy”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
EU Grants€2,025,511
All-time revenue—
MRRPrivate••••••
Founder—
Founded—
🇨🇭Switzerland
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics
Startup insights
Value proposition
PHILOCHEM AG is a private SME recorded in CORDIS in Switzerland, with participation in 5 EU research and innovation projects. Its recorded projects include “Small-Molecule Drug Conjugates for Targeted Delivery in Tumor Therapy”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
Biotech
Tags:Biotech
Company Info
PHILOCHEM AG Info
Funding
EU Grants€2,025,511